1. Home
  2. HIMS
  3. HIMS News

Latest Hims & Hers Health Inc. (HIMS) News on December 22, 2024

IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
HIMS

Investor's Business Daily

3 days ago

IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List

Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls
HIMS

Yahoo Finance Video

3 days ago

Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next
HIMS

Yahoo Finance

3 days ago

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

HIMS

Argus Research

5 days ago

HIMS: Raising target price to $33.00

Tesla, crypto miners, Hims & Hers Health: Trending Tickers
HIMS

Yahoo Finance Video

5 days ago

Tesla, crypto miners, Hims & Hers Health: Trending Tickers

The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
HIMS

Business Wire

10 days ago

The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight

HIMS

Argus Research

12 days ago

HIMS: Lowering target price to $32.00

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
HIMS

Investor's Business Daily

17 days ago

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market

3 US Stocks Estimated To Be Trading Up To 47.6% Below Intrinsic Value
HIMS

Simply Wall St.

17 days ago

3 US Stocks Estimated To Be Trading Up To 47.6% Below Intrinsic Value

HIMS

Argus Research

19 days ago

HIMS: Raising target price to $34.00

Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
HIMS

Business Wire

19 days ago

Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category

Hims & Hers surges: Analysts say it's well-positioned under Trump
HIMS

Yahoo Finance Video

a month ago

Hims & Hers surges: Analysts say it's well-positioned under Trump

3 US Growth Companies With High Insider Ownership Seeing Up To 40% Earnings Growth
HIMS

Simply Wall St.

a month ago

3 US Growth Companies With High Insider Ownership Seeing Up To 40% Earnings Growth

Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
HIMS

Business Wire

a month ago

Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys

Guardant Health Stock Sees RS Rating Jump To 83
HIMS

Investor's Business Daily

a month ago

Guardant Health Stock Sees RS Rating Jump To 83

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
HIMS

Business Wire

a month ago

Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions

Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally
HIMS

Investor's Business Daily

a month ago

Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally

Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
HIMS

The Wall Street Journal

a month ago

Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments

Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
HIMS

Yahoo Finance

a month ago

Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision

Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
HIMS

Business Wire

a month ago

Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue

HIMS

Argus Research

a month ago

HIMS: Raising target price to $28.00

Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality
HIMS

Simply Wall St.

a month ago

Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality

Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
HIMS

Simply Wall St.

2 months ago

Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

HIMS

Argus Research

2 months ago

HIMS: Lowering target price to $22.00

Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories
HIMS

Yahoo Finance Video

2 months ago

Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories

Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims
HIMS

The Wall Street Journal

2 months ago

Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims

Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.
HIMS

Yahoo Finance Video

2 months ago

Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory
HIMS

Investor's Business Daily

2 months ago

IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
HIMS

Business Wire

2 months ago

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
HIMS

Business Wire

2 months ago

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage
HIMS

Yahoo Finance

2 months ago

Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage

Define Ventures Appoints Bruce Broussard as Venture Partner
HIMS

PR Newswire

2 months ago

Define Ventures Appoints Bruce Broussard as Venture Partner

Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug
HIMS

Investor's Business Daily

2 months ago

Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
HIMS

Business Wire

2 months ago

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers

FDA not planning to take action against GLP-1 compounders, Endpoints says
HIMS

TipRanks

2 months ago

FDA not planning to take action against GLP-1 compounders, Endpoints says

3 US Growth Companies With Significant Insider Ownership
HIMS

Simply Wall St.

2 months ago

3 US Growth Companies With Significant Insider Ownership

Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk.
HIMS

Investor's Business Daily

2 months ago

Hims & Hers Shares Rallied 22% Over Two Days. Why That Move Is Now At Risk.

Walgreens closing 1,200 stores over next 3 years, 800 more under evaluation
HIMS

Yahoo Finance

2 months ago

Walgreens closing 1,200 stores over next 3 years, 800 more under evaluation

Do Its Financials Have Any Role To Play In Driving Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Up Recently?
HIMS

Simply Wall St.

2 months ago

Do Its Financials Have Any Role To Play In Driving Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Up Recently?

Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
HIMS

Investor's Business Daily

2 months ago

Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug

HIMS

Business Wire

2 months ago

Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024

Hims & Hers surges as FDA mulls over compounded drugs limit
HIMS

Yahoo Finance Video

2 months ago

Hims & Hers surges as FDA mulls over compounded drugs limit

WeightWatchers rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.'
HIMS

Yahoo Finance

2 months ago

WeightWatchers rallies 170%! But new compounded GLP-1 drug is 'not a sustainable long-term business model.'

WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'
HIMS

Yahoo Finance

2 months ago

WeightWatchers stock soars, but its cheap Wegovy knockoff 'is not a sustainable long-term business model'

Hims & Hers Health Set to Join S&P SmallCap 600
HIMS

PR Newswire

3 months ago

Hims & Hers Health Set to Join S&P SmallCap 600

Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list
HIMS

Yahoo Finance Video

3 months ago

Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list

For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
HIMS

The Wall Street Journal

3 months ago

For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away

Stocks to Watch Thursday: Levi Strauss, Hims & Hers, Constellation Brands, Nvidia
HIMS

The Wall Street Journal

3 months ago

Stocks to Watch Thursday: Levi Strauss, Hims & Hers, Constellation Brands, Nvidia

Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list
HIMS

Yahoo Finance Video

3 months ago

Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
HIMS

Business Wire

3 months ago

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

3 US Insider Picks With Earnings Growth Up To 98%
HIMS

Simply Wall St.

3 months ago

3 US Insider Picks With Earnings Growth Up To 98%

Hims & Hers Health, Inc.'s (NYSE:HIMS) large institutional owners must be happy as stock continues to impress, up 19% over the past week
HIMS

Simply Wall St.

3 months ago

Hims & Hers Health, Inc.'s (NYSE:HIMS) large institutional owners must be happy as stock continues to impress, up 19% over the past week

Why Big Pharma is betting on telehealth strategies
HIMS

Yahoo Finance

4 months ago

Why Big Pharma is betting on telehealth strategies

Why Eli Lilly is 'the Nvidia of GLP-1' weight-loss drugs
HIMS

Yahoo Finance Video

4 months ago

Why Eli Lilly is 'the Nvidia of GLP-1' weight-loss drugs

Top 3 Growth Stocks With High Insider Ownership And Up To 40% Earnings Growth
HIMS

Simply Wall St.

4 months ago

Top 3 Growth Stocks With High Insider Ownership And Up To 40% Earnings Growth

What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales
HIMS

Yahoo Finance

4 months ago

What Eli Lilly, Novo Nordisk earnings reveal about the future of GLP-1 sales

Bullish: Analysts Just Made A Neat Upgrade To Their Hims & Hers Health, Inc. (NYSE:HIMS) Forecasts
HIMS

Simply Wall St.

4 months ago

Bullish: Analysts Just Made A Neat Upgrade To Their Hims & Hers Health, Inc. (NYSE:HIMS) Forecasts

Hims & Hers Health Second Quarter 2024 Earnings: Beats Expectations
HIMS

Simply Wall St.

4 months ago

Hims & Hers Health Second Quarter 2024 Earnings: Beats Expectations

Stocks to Watch Tuesday: Uber, Caterpillar, Palantir, Lucid
HIMS

The Wall Street Journal

5 months ago

Stocks to Watch Tuesday: Uber, Caterpillar, Palantir, Lucid

Hims & Hers Health, FuboTV, Celsius: 3 Stock in Focus
HIMS

Yahoo Finance Video

5 months ago

Hims & Hers Health, FuboTV, Celsius: 3 Stock in Focus

Lucid, Hims & Hers Health, Chegg: After-hours Movers
HIMS

Yahoo Finance Video

5 months ago

Lucid, Hims & Hers Health, Chegg: After-hours Movers

Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
HIMS

Business Wire

5 months ago

Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results

Hims & Hers Health Stock Flashing Buy Signal Before Earnings
HIMS

Schaeffer's Investment Research

5 months ago

Hims & Hers Health Stock Flashing Buy Signal Before Earnings

Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
HIMS

Business Wire

5 months ago

Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board

HIMS

Business Wire

5 months ago

Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024

US Growth Companies With High Insider Ownership In July 2024
HIMS

Simply Wall St.

5 months ago

US Growth Companies With High Insider Ownership In July 2024

Hims & Hers Down Sharply Again as Scrutiny Over Ozempic Knockoff Business Grows
HIMS

The Wall Street Journal

6 months ago

Hims & Hers Down Sharply Again as Scrutiny Over Ozempic Knockoff Business Grows

Heard on the Street Wednesday Recap: Land of the Rising Sum
HIMS

The Wall Street Journal

6 months ago

Heard on the Street Wednesday Recap: Land of the Rising Sum

The War Over Cheaper Ozempic Won’t End Well for Some Investors
HIMS

The Wall Street Journal

6 months ago

The War Over Cheaper Ozempic Won’t End Well for Some Investors

Explore These 3 US Growth Companies With High Insider Ownership
HIMS

Simply Wall St.

6 months ago

Explore These 3 US Growth Companies With High Insider Ownership

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week
HIMS

The Wall Street Journal

7 months ago

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week

Nvidia earnings, housing market outlook, BNPL regulatory pressure: Market Domination
HIMS

Yahoo Finance Video

7 months ago

Nvidia earnings, housing market outlook, BNPL regulatory pressure: Market Domination

Citigroup downgrades Hims & Hers Health to Neutral from Buy
HIMS

Yahoo Finance Video

7 months ago

Citigroup downgrades Hims & Hers Health to Neutral from Buy

Investors await Nvidia earnings, commodities on the rise: Morning Brief
HIMS

Yahoo Finance Video

7 months ago

Investors await Nvidia earnings, commodities on the rise: Morning Brief

Investors eye chip stocks, Palo Alto Networks earnings on tap: Yahoo Finance
HIMS

Yahoo Finance Video

7 months ago

Investors eye chip stocks, Palo Alto Networks earnings on tap: Yahoo Finance

Heard on the Street: Hims Is Jumping on a Crowded Ozempic Bandwagon
HIMS

The Wall Street Journal

7 months ago

Heard on the Street: Hims Is Jumping on a Crowded Ozempic Bandwagon

Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform
HIMS

The Wall Street Journal

7 months ago

Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform

Weight loss: Hims & Hers introduce access to GLP-1 injections
HIMS

Yahoo Finance Video

7 months ago

Weight loss: Hims & Hers introduce access to GLP-1 injections

Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
HIMS

Business Wire

7 months ago

Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers

Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
HIMS

Business Wire

7 months ago

Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors

High Insider Ownership Growth Stocks On US Exchange For May 2024
HIMS

Simply Wall St.

7 months ago

High Insider Ownership Growth Stocks On US Exchange For May 2024

Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
HIMS

Simply Wall St.

7 months ago

Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Oscar Health, Kenvue, Hims & Hers: Health earnings roundup
HIMS

Yahoo Finance Video

7 months ago

Oscar Health, Kenvue, Hims & Hers: Health earnings roundup

Telehealth Stock Gains Popularity With Options Bulls
HIMS

Schaeffer's Investment Research

8 months ago

Telehealth Stock Gains Popularity With Options Bulls

Him & Hers Health stock soars on Q1 revenue beat, Q2 guidance
HIMS

Yahoo Finance Video

8 months ago

Him & Hers Health stock soars on Q1 revenue beat, Q2 guidance

Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
HIMS

Business Wire

8 months ago

Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results

Jefferies downgrades Hims & Hers Health on growth concerns
HIMS

Yahoo Finance Video

8 months ago

Jefferies downgrades Hims & Hers Health on growth concerns

Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
HIMS

Business Wire

8 months ago

Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024

Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
HIMS

Business Wire

9 months ago

Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member

Nvidia's valuation forecasts aren't 'justified': Portfolio manager
HIMS

Yahoo Finance Video

9 months ago

Nvidia's valuation forecasts aren't 'justified': Portfolio manager

HIMS

Business Wire

9 months ago

Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024

Hims & Hers Health, Unity Software: After-Hours Movers
HIMS

Yahoo Finance Video

10 months ago

Hims & Hers Health, Unity Software: After-Hours Movers

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
HIMS

Business Wire

10 months ago

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
HIMS

Business Wire

10 months ago

Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer

HIMS

Business Wire

a year ago

Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

eXp World Holdings to Announce Full-Year and Fourth Quarter 2023 Results on February 22, 2024
HIMS

GlobeNewswire

a year ago

eXp World Holdings to Announce Full-Year and Fourth Quarter 2023 Results on February 22, 2024

EPA Selects ICF for $33 Million in New Environmental Assessment Contracts
HIMS

PR Newswire

a year ago

EPA Selects ICF for $33 Million in New Environmental Assessment Contracts

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education
HIMS

PR Newswire

a year ago

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education

Stock-Split Watch: 2 Red-Hot Stocks That Could Split Their Shares in 2024
HIMS

Motley Fool

a year ago

Stock-Split Watch: 2 Red-Hot Stocks That Could Split Their Shares in 2024

First Financial Bancorp. (NASDAQ:FFBC) Q4 2023 Earnings Call Transcript
HIMS

Insider Monkey

a year ago

First Financial Bancorp. (NASDAQ:FFBC) Q4 2023 Earnings Call Transcript

Share on Social Networks: